Suchergebnisse - "Meyer, Antoine"

PubPharm (5)

1

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era

enthalten in: Viruses | 2022

von Zerbit, J. | Detroit, M. | Meyer, A. | +12

2

HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients

enthalten in: Critical care (London, England) | 2021

von Meyer, A. | Buetti, N. | Houhou-Fidouh, N. | +13

3

The outcome of Crohn's disease patients refractory to anti-TNF and either vedolizumab or ustekinumab

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Kassouri, L. | Amiot, A. | Kirchgesner, J. | +6

4

Maintenance of Remission Among Patients With Inflammatory Bowel Disease After Vedolizumab Discontinuation : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2020

von Martin, A. | Nachury, M. | Peyrin-Biroulet, L. | +62

5

The effectiveness of either ustekinumab or vedolizumab in 239 patients with Crohn's disease refractory to anti-tumour necrosis factor

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Alric, H. | Amiot, A. | Kirchgesner, J. | +6

CommentIn: Aliment Pharmacol Ther. 2020 Aug;52(3):561-562. - PMID 32656826

1
[1]